Cargando…
Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?
As the advanced form of nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) will significantly increase the risks of liver fibrosis, cirrhosis, and HCC. However, there is no non-invasive method to distinguish NASH from NAFLD so far. Additionally, liver biopsy remains the go...
Autores principales: | Zhang, Lei, Mao, Yilei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818843/ https://www.ncbi.nlm.nih.gov/pubmed/36611577 http://dx.doi.org/10.3390/healthcare11010117 |
Ejemplares similares
-
Radiomics based on artificial intelligence in liver diseases: where are we?
por: Hu, Wenmo, et al.
Publicado: (2020) -
Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging
por: Franzé, Silvia, et al.
Publicado: (2018) -
From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2014) -
Clinical and FDG-PET/CT Suspicion of Malignant Disease: Is Biopsy Confirmation Still Necessary?
por: Bent, Talitha, et al.
Publicado: (2021) -
Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)